Erin M Rock Selected Research

Cannabinoid Hyperemesis Syndrome

1/2022	Cannabidiol Interferes with Establishment of Δ9-Tetrahydrocannabinol-Induced Nausea Through a 5-HT1A Mechanism.
7/2020	Role of the stress response and the endocannabinoid system in Δ9-tetrahydrocannabinol (THC)-induced nausea.
1/2020	Nausea-Induced Conditioned Gaping Reactions in Rats Produced by High-Dose Synthetic Cannabinoid, JWH-018.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erin M Rock Research Topics

Disease

32	Nausea 02/2022 - 02/2008
15	Vomiting 02/2022 - 02/2009
3	Cannabinoid Hyperemesis Syndrome 01/2022 - 01/2020
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Hyperthermia 01/2021
1	Chronic Disease (Chronic Diseases) 09/2020
1	Tobacco Use Disorder (Nicotine Dependence) 09/2020
1	Anhedonia 09/2020
1	Body Weight (Weight, Body) 02/2020
1	Diarrhea 02/2020
1	Pain (Aches) 11/2018
1	Inflammation (Inflammations) 11/2018
1	Edema (Dropsy) 11/2018
1	Hyperalgesia 11/2018
1	Anxiety Disorders (Anxiety Disorder) 01/2018
1	Shock 07/2017
1	Medically Unexplained Symptoms 01/2016
1	Neoplasms (Cancer) 08/2014

Drug/Important Bio-Agent (IBA)

17	CannabinoidsIBA 01/2021 - 06/2011
12	Lithium ChlorideIBA 02/2022 - 10/2013
11	AntiemeticsIBA 02/2022 - 06/2011
11	Dronabinol (THC)FDA LinkGeneric 01/2022 - 10/2013
11	CannabidiolIBA 01/2022 - 02/2008
10	cannabidiolic acidIBA 01/2021 - 08/2014
7	EndocannabinoidsIBA 07/2020 - 02/2008
7	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2020 - 10/2013
5	Morphine (MS Contin)FDA LinkGeneric 02/2022 - 01/2016
5	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2019 - 08/2011
4	Naloxone (Narcan)FDA LinkGeneric 02/2022 - 02/2020
4	5-HT1A Serotonin ReceptorIBA 01/2022 - 06/2011
4	SaccharinIBA 09/2020 - 06/2011
4	Pharmaceutical PreparationsIBA 07/2020 - 06/2011
4	Monoacylglycerol LipasesIBA 07/2018 - 04/2012
4	Glycerol (Glycerine)FDA LinkGeneric 01/2016 - 04/2012
3	Fatty Acids (Saturated Fatty Acids)IBA 02/2022 - 09/2020
3	AmidesIBA 02/2022 - 09/2020
3	EstersIBA 01/2021 - 01/2018
3	Serotonin (5 Hydroxytryptamine)IBA 09/2020 - 08/2011
3	RimonabantIBA 11/2018 - 10/2013
3	Ondansetron (Zofran)FDA LinkGeneric 07/2018 - 08/2014
3	MJN110IBA 07/2018 - 02/2015
3	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 10/2015 - 02/2008
2	muskIBA 02/2022 - 06/2015
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2022 - 09/2020
2	Alanine (L-Alanine)FDA Link 02/2022 - 09/2020
2	N-oleoylglycineIBA 01/2021 - 02/2020
2	HU-580IBA 09/2020 - 01/2018
2	anandamide (arachidonylethanolamide)IBA 09/2020 - 01/2016
2	MK-886IBA 03/2020 - 10/2015
2	PF 3845IBA 01/2019 - 10/2015
2	GW 7647IBA 01/2019 - 11/2017
2	AutoreceptorsIBA 07/2018 - 08/2011
2	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 01/2018 - 06/2011
2	Aprepitant (Emend)FDA Link 01/2016 - 08/2014
2	AM 251 (AM251)IBA 10/2013 - 04/2012
1	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 01/2022
1	PPAR alphaIBA 03/2020
1	AcidsIBA 03/2020
1	SC 24IBA 02/2020
1	1-pentyl-3-(1-naphthoyl)indoleIBA 01/2020
1	CorticosteroneIBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	Transient Receptor Potential ChannelsIBA 11/2018
1	3- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA 11/2018
1	CarrageenanIBA 11/2018
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 07/2018
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 07/2018
1	1-(3-chlorophenyl)biguanideIBA 07/2018
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2018
1	tetralinIBA 01/2018
1	Serotonin 5-HT1 Receptor AntagonistsIBA 01/2018
1	URB937IBA 11/2017
1	CB2 Cannabinoid ReceptorIBA 09/2016
1	iodopravadoline (AM 630)IBA 09/2016
1	HU 308IBA 09/2016
1	Lipase (Acid Lipase)FDA Link 01/2016
1	MonoglyceridesIBA 01/2016
1	Neurokinin-1 Receptor AntagonistsIBA 08/2014
1	cannabidivarinIBA 10/2013
1	JZL 184IBA 04/2012
1	Arachidonic Acid (Vitamin F)IBA 04/2012
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2012
1	EmeticsIBA 08/2011
1	Cannabinoid Receptor AgonistsIBA 08/2011
1	Calcium Gluconate (CBG)IBA 06/2011
1	cannabigerolIBA 06/2011
1	Phosphodiesterase 4 InhibitorsIBA 02/2009
1	RolipramIBA 02/2009
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 02/2009
1	LithiumIBA 02/2008

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 03/2020 - 02/2008
1	Injections 01/2020
1	Oral Administration 09/2016
1	Therapeutics 04/2016